PCIA
GMAB icon

Prime Capital Investment Advisors’s Genmab GMAB Stock Holding History

Prime Capital Investment Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-466
Closed -$10K – 524
2019
Q4 		$10K Hold
466
– – ﹤0.01% 492
2019
Q3 		$9K Buy
+466
New +$9.18K ﹤0.01% 531

Other funds holding GMAB

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Prime Capital Investment Advisors's GMAB Position: Q1 2020 in Review

Prime Capital Investment Advisors sold out of Genmab (GMAB) in Q1 2020, closing a stake of 466 shares — an estimated $10K sold.

Prime Capital Investment Advisors first reported a position in GMAB in Q3 2019 and held it in 2 quarters. The position peaked at $10K in Q4 2019. 143 funds tracked by Wall St. Rank hold GMAB as of Q1 2020.

  • Prime Capital Investment Advisors reported no remaining Genmab position as of Q1 2020 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 466 Genmab shares in Q1 2020, an estimated $10K.
  • Prime Capital Investment Advisors first reported a position in Genmab in Q3 2019 and held it in 2 quarters.
  • Prime Capital Investment Advisors's Genmab position peaked at $10K in Q4 2019.
  • 143 funds tracked by Wall St. Rank held Genmab as of Q1 2020.

Based on Prime Capital Investment Advisors's 13F filing for Q1 2020, filed 4 May 2020.